[1] Cui YC, Pan CS, Yan L, et al. Ginsenoside Rb1 protects against ischemia/reperfusion-induced myocardial injury via energy metabolism regulation mediated by RhoA signaling pathway[J]. Sci Rep, 2017, 7:44579.
[2] Sun T, Dong YH, Du W, et al. The role of microRNAs in myocardial infarction: from molecular mechanism to clinical application[J]. Int J Mol Sci, 2017, 18(4):E745.
[3] Neri M, Riezzo I, Pascale N, et al. Ischemia/reperfusion injury following acute myocardial infarction: a critical issue for clinicians and forensic pathologists[J]. Mediators Inflamm, 2017, 2017:7018393.
[4] Wang F, Li H, Qiao JO. 1-O-acetylbritannilactone combined with gemcitabine elicits growth inhibition and apoptosis in A549 human non-small cell lung cancer cells[J]. Mol Med Rep, 2015, 12(4):5568-5572.
[5] Choo SJ, Ryoo IJ, Kim KC, et al. Hypo-pigmenting effect of sesquiterpenes from Inula britannica in B16 melanoma cells[J]. Arch Pharm Res, 2014, 37(5):567-574.
[6] Dong M, Hong T, Liu SA, et al. Hepatoprotective effect of the flavonoid fraction isolated from the flower of Inula britannica against D-Galactosamine-induced hepatic injury[J]. Mol Med Rep, 2013, 7(6):1919-1923.
[7] Kim N, Hwangbo C, Lee S, et al. Eupatolide inhibits PDGF-induced proliferation and migration of aortic smooth muscle cells through ROS-dependent heme oxygenase-1 induction[J]. Phytother Res, 2013, 27(11):1700-1707.
[8] Han M, Wen JK, Zheng B, et al. Acetylbritannilatone suppresses NO and PGE2 synthesis in RAW 264.7 macrophages through the inhibition of iNOS and COX-2 gene expression[J]. Life Sci, 2004, 75(6):675-684.
[9] Liu B, Han M, Wen JK. Acetylbritannilactone inhibits neointimal hyperplasia after balloon injury of rat artery by suppressing nuclear factor-kappa B activation[J]. J Pharmacol Exp Ther, 2008, 324(1):292-298.
[10] Zhao J, NiuH, LiA, et al. Acetylbritannilactone modulates vascular endothelial growth factor signaling and regulates angiogenesis in endothelial cells[J]. PLoS One, 2016, 11(2):e0148968.
[11] Sun N, Wang H, Wang L. Protective effects of ghrelin against oxidative stress, inducible nitric oxide synthase and inflammation in a mouse model of myocardial ischemia/reperfusion injury via the HMGB1 and TLR4/NF-κB pathway[J]. Mol Med Rep, 2016, 14(3):2764-2770.
[12] Diaz A, Humeres C, Gonzalez V, et al. Insulin/NFκB protects against ischemia-induced necrotic cardiomyocyte death[J]. Biochem Biophys Res Commun, 2015, 467(2):451-457.
[13] Wang BZ, Yu ZG. The combination use of 1-O-acetylbritannilactone(ABL)and gemcitabine inhibits cell growth and induces cell apoptosis in lung adenocarcinoma cells[J]. Pharmazie, 2016, 71(4):213-217.
[14] Guo J, Wang SB, Yuan TY, et al. Coptisine protects rat heart against myocardial ischemia/reperfusion injury by suppressing myocardial apoptosis and inflammation[J]. Atherosclerosis, 2013, 231(2):384-391.
[15] Marchant DJ, Boyd JH, Lin DC, et al. Inflammation in myocardial diseases[J]. Circ Res, 2012, 110(1):126-144.
[16] Vander Heide RS, Steenbergen C. Cardioprotection and myocardial reperfusion: pitfalls to clinical application[J]. Circ Res, 2013, 113(4):464-477.
[17] Yang Y, Ding S, Xu GJ, et al. MicroRNA-15a inhibition protects against hypoxia/reoxygenation-induced apoptosis of cardiomyocytes by targeting mothers against decapentaplegic homolog 7[J]. Mol Med Rep, 2017, 15(6):3699-3705.
[18] Kim YS, Kim JS, Kwon JS, et al. BAY 11-7082, a nuclear factor-kappa B inhibitor, reduces inflammation and apoptosis in a rat cardiac ischemia-reperfusion injury model[J]. Int Heart J, 2010, 51(5):348-353.